Essilor’s latest innovation honored at SILMO – Salon Mondial de
Charenton-le-Pont, France (October 5, 2012) – Essilor, the world leader in ophthalmic optics, was
awarded the top prize for Varilux S series lenses in the “Vision” category at the Silmo d’Or awards,
yesterday in France.
“This award demonstrates the success of our innovation strategy, which enables us to offer consumers
ever more innovative and effective solutions for correcting their vision and procuring the best possible
visual comfort. We are proud of this recognition by our peers of our ongoing efforts to improve vision
around the world, a mission to which all the Group’s teams are committed each day, in every country
where we do business,” declared Hubert Sagnières, Essilor Chairman and Chief Executive Officer.
This Silmo d’Or rewards the technological achievement of Essilor’s teams who have created new lenses
that revolutionize presbyopia correction. More than 50 years after the invention of Varilux, the new
Varilux S series range of progressive lenses is a major technological advance designed to bring better
vision to the nearly two billion presbyopes around the globe. Two patented* technologies, Nanoptix™ and
Synchroneyes™, push technological barriers and make Varilux S series truly unique lenses that offer a
large field of vision, equilibrium in motion and reduced adaptation time.
Essilor, the world leader in ophthalmic optics, has placed innovation at the heart of its growth strategy.
The Group annually devotes €150 million to research and development, in its three Innovation and
Technology Centers, in order to develop tomorrow’s innovations and meet consumers’ vision health
Each year the Silmo d’Or rewards the creativity and inventive spirit of an entire profession.
Varilux® is a registered trademark of Essilor International
*: patent applications under examination
The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide
range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the
world to access lenses that meet his or her unique vision requirements. To support this mission, the
Company allocates around €150 million to research and development every year, in a commitment to
continuously bring new, more effective products to market. Essilor’s flagship brands Varilux , Crizal ,
® ® ®
Definity , Xperio , Optifog™ and Foster Grant . Essilor also develops and markets equipment,
instruments and services for eyecare professionals.
Essilor reported consolidated revenue of €4.2 billion in 2011 and employs around 48,700 people in
some 100 countries. It operates 19 plants, a total of 390 prescription laboratories and edging facilities,
as well as several research and development centers around the world.
Essilor was named one of the 30 most innovative companies in the world by Forbes magazine.
Essilor shares trades on the NYSE Euronext Paris market and is included in the CAC 40 and Euro
Codes: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP. For more information please visit
Corporate and Press Communications
Tel.: +33 (0)1 49 77 42 66
Page 2 of 2